glp 1 cancer GLP-1 drugs may reduce the risk of progressing, study suggests Does GLP-1 Increase Risk of

Immune and oxidative changes during and following the Western States Endurance Run

The most commonly reported changes after stopping GLP-1 medications include: Return of appetite : The appetite-suppressing effects diminish, and many people notice increased hunger and food cravings returning to pre-treatment levels Weight regain : Clinical evidence consistently shows that most individuals regain weight after discontinuation, often within 312 months Rising blood glucose levels : For those with type 2 diabetes, HbA1c levels typically increase, sometimes returning to pre-treatment values Changes in eating patterns : Gastric emptying returns to normal speed, which may affect feelings of fullness after meals It's important to note that stopping GLP-1 medications is generally safe from a withdrawal perspectivethese drugs do not cause physical dependence or withdrawal symptoms in the way some medications do, and tapering is not typically required

Gallbladder events : As with other incretin-based therapies, there is a potential risk of gallbladder disease, including cholelithiasis (gallstones)

552, 554 Huras, H

Injection site reactions, transient fatigue, and mild headaches occur but typically resolve quickly